These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3515657)

  • 1. Cyclosporine-associated microangiopathy in renal transplantation: a severe but potentially reversible form of early graft injury.
    Walfe JA; McCann RL; Sanfilippo F
    Transplantation; 1986 Apr; 41(4):541-4. PubMed ID: 3515657
    [No Abstract]   [Full Text] [Related]  

  • 2. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage.
    Ohshima S; Fujita T; Asano H; Ono Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2081-4. PubMed ID: 3547911
    [No Abstract]   [Full Text] [Related]  

  • 4. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 6. An interim analysis of the on-going long-term safety study of cyclosporine in renal transplantation.
    Cockburn I; Götz E; Gülich A; Krupp P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):519-29. PubMed ID: 3291290
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
    Quarto Di Palo F; Elli A; Rivolta R; Parenti M; Palazzi P; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):969-71. PubMed ID: 1989347
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of ultrasound in the diagnosis of cyclosporine toxicity in renal transplantation.
    Bergren CT; Toledo-Pereyra LH; Craig BM; Fawcett KJ
    Bol Asoc Med P R; 1986 Feb; 78(2):50-4. PubMed ID: 3518734
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of serial serum trough cyclosporine levels in human renal transplantation.
    Kahan BD; Wideman CA; Reid M; Gibbons S; Jarowenko M; Flechner S; Van Buren CT
    Transplant Proc; 1984 Oct; 16(5):1195-9. PubMed ID: 6385376
    [No Abstract]   [Full Text] [Related]  

  • 11. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential protective effects of furosemide against early cyclosporine-induced renal injury in hepatic transplant recipients.
    Driscoll DF; Pinson CW; Jenkins RL; Bistrian BR
    Transplant Proc; 1989 Jun; 21(3):3549-50. PubMed ID: 2662523
    [No Abstract]   [Full Text] [Related]  

  • 13. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of fractional excretion of sodium as index of cyclosporine nephrotoxicity in renal transplantation.
    Morales JM; Andres A; Alcazar JM; Prieto C; Diaz de Tueste I; Ruilope LM; Rodicio JL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):691-9. PubMed ID: 3291305
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical summation. An algorithm for the management of patients with cyclosporine-induced renal dysfunction.
    Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):303-8. PubMed ID: 3895669
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse effects of cyclosporine A on the microcirculation of the cold preserved kidney.
    Anaise D; Waltzer WC; Arnold AN; Rapaport FT
    N Y State J Med; 1987 Mar; 87(3):141-2. PubMed ID: 3554040
    [No Abstract]   [Full Text] [Related]  

  • 18. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.